The therapeutic efficacy of PD-1 mAb on tumor growth was almost completely abolished by co-administration of neutralizing Abs against IFNAR1 and TNFR (Fig. 7c and Supplementary Fig. S6b–d). This evidence concerns the gene IFNAR1 and neoplasm.